Thromb Haemost 1994; 72(03): 481-482
DOI: 10.1055/s-0038-1648893
Original Article
Schattauer GmbH Stuttgart

Patients with AT III, Protein C or Protein S Defects Show no Associated Hereditary APC-Resistance

Paolo Simioni
Institute of Medical Semeiotics, University of Padua Medical School, Padua, Italy
,
Paolo Prandoni
Institute of Medical Semeiotics, University of Padua Medical School, Padua, Italy
,
Antonio Girolami
Institute of Medical Semeiotics, University of Padua Medical School, Padua, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 28. April 1994

Accepted after revision 26. Mai 1994

Publikationsdatum:
25. Juli 2018 (online)

 
  • References

  • 1 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
  • 2 Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503-1506
  • 3 Griffin JH, Evatt B, Wideman C, Fernàndez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993
  • 4 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
  • 5 Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396-1400
  • 6 Halbmayer W-M, Haushofer A, Schon R, Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul and Fibrinol 1994; 5: 51-57